OncoResponse

909 Fannin Street
Suite 2100
Houston
Texas
77024
United States

Tel: 206-805-1600
Fax: 206-805-1699

Email: info@oncoresponseinc.com

Show jobs for this employer

About OncoResponse


OncoResponse, a privately held immuno-oncology company, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to the discovery of cancer therapeutics.

OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer, thereby extending the benefit of immunotherapy to a greater number of patients.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Clifford J. Stocks

CSO: Kristine Swiderek, Ph.D.

CFO: Russ Hawkinson

TECHNOLOGY:

Please click here for OncoResponse's technology.

8 articles with OncoResponse